GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diva Laboratories Ltd (ROCO:4153) » Definitions » Cyclically Adjusted FCF per Share

Diva Laboratories (ROCO:4153) Cyclically Adjusted FCF per Share : NT$1.05 (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Diva Laboratories Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Diva Laboratories's adjusted free cash flow per share for the three months ended in Mar. 2025 was NT$0.042. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$1.05 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Diva Laboratories's average Cyclically Adjusted FCF Growth Rate was 16.70% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Diva Laboratories was 10.50% per year. The lowest was -3.10% per year. And the median was 3.70% per year.

As of today (2025-05-27), Diva Laboratories's current stock price is NT$41.90. Diva Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was NT$1.05. Diva Laboratories's Cyclically Adjusted Price-to-FCF of today is 39.90.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Diva Laboratories was 86.62. The lowest was 24.49. And the median was 42.65.


Diva Laboratories Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Diva Laboratories's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diva Laboratories Cyclically Adjusted FCF per Share Chart

Diva Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.88 0.80 0.63 0.80 1.08

Diva Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 0.96 1.02 1.08 1.05

Competitive Comparison of Diva Laboratories's Cyclically Adjusted FCF per Share

For the Diagnostics & Research subindustry, Diva Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diva Laboratories's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diva Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Diva Laboratories's Cyclically Adjusted Price-to-FCF falls into.


;
;

Diva Laboratories Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Diva Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.042/134.9266*134.9266
=0.042

Current CPI (Mar. 2025) = 134.9266.

Diva Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.390 100.684 -0.523
201509 2.793 100.392 3.754
201512 1.091 99.792 1.475
201603 -1.844 100.470 -2.476
201606 -2.484 101.688 -3.296
201609 -0.384 101.861 -0.509
201612 2.331 101.863 3.088
201703 -1.356 102.862 -1.779
201706 0.162 103.349 0.211
201709 0.403 104.136 0.522
201712 1.237 104.011 1.605
201803 1.187 105.290 1.521
201806 -0.344 106.317 -0.437
201809 0.241 106.507 0.305
201812 0.023 105.998 0.029
201903 -0.129 107.251 -0.162
201906 -0.052 108.070 -0.065
201909 0.182 108.329 0.227
201912 0.369 108.420 0.459
202003 -0.033 108.902 -0.041
202006 -0.125 108.767 -0.155
202009 -1.223 109.815 -1.503
202012 0.914 109.897 1.122
202103 0.201 111.754 0.243
202106 0.022 114.631 0.026
202109 -0.719 115.734 -0.838
202112 0.079 117.630 0.091
202203 -1.665 121.301 -1.852
202206 0.667 125.017 0.720
202209 0.141 125.227 0.152
202212 1.910 125.222 2.058
202303 0.335 127.348 0.355
202306 2.524 128.729 2.646
202309 0.011 129.860 0.011
202312 1.300 129.419 1.355
202403 0.793 131.776 0.812
202406 0.350 132.554 0.356
202409 0.203 133.029 0.206
202412 0.696 133.157 0.705
202503 0.042 134.927 0.042

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Diva Laboratories  (ROCO:4153) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Diva Laboratories's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=41.90/1.05
=39.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Diva Laboratories was 86.62. The lowest was 24.49. And the median was 42.65.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Diva Laboratories Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Diva Laboratories's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Diva Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Zhongshan Road, 9F, No. 351, Sector 2, Zhonghe District, New Taipei City, TWN, 235
Diva Laboratories Ltd is a Taiwan-based company that engages in the sale, manufacturing, and development of medical equipment and computer-related devices. It offers endo/surgical displays; color displays for radiology and medical imaging services; touch displays; and original design manufacturing and original equipment manufacturing solutions.

Diva Laboratories Headlines

No Headlines